EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Clinical and biomarker significance of interleukin-4 and interleukin-13 in acute exacerbations and the frequent exacerbator phenotype of chronic obstructive pulmonary disease: a systematic review

Ombretta Para, Asim Raza, Christian Carleo, Marco Vanetti, Antonio Spanevello

Monaldi Archives for Chest Disease · 17.11.2026

DOI: 10.4081/monaldi.2026.4037 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Monaldi Archives for Chest Disease, online erschienen am 17.11.2026. Verfasst von Ombretta Para und 4 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are one of the major causes of morbidity, mortality, and hospitalization; reliable inflammatory biomarkers predicting exacerbation risk and guiding emerging interleukin (IL)-targeted therapies are still undefined. IL-4 and IL-13 are key T-helper 2 cytokines implicated in eosinophilic airway inflammation and remodeling, but their clinical and prognostic relevance in COPD is still controversial. MEDLINE and EMBASE databases were manually searched from inception to December 2025, including observational studies reporting quantitative IL-4 and/or IL-13 levels in adults with COPD and healthy controls, with measurements in serum by enzyme-linked immunosorbent assay or V-PLEX immunoassay. Study selection, data extraction, and quality assessment (Newcastle-Ottawa Scale) were performed independently by three reviewers, following PRISMA recommendations. Of 1147 records screened, 5 cohort studies (total patient number: 1168) met inclusion criteria. Across studies, serum IL-4 was consistently higher in AECOPD than in healthy controls, with IL-13 also frequently elevated during exacerbations. Comparisons between AECOPD and stable COPD yielded non-significant results. Two studies reported higher serum IL-4 in frequent versus infrequent exacerbators, whereas IL-13 was not as significantly high as IL-4. In stable COPD, IL-4 and IL-13 showed only modest, often non-significant increases versus controls. Available evidence suggests that IL-4 and IL-13 are variably upregulated in COPD, with more pronounced elevations during AECOPD and a possible association between higher IL-4 and frequent exacerbations. However, small sample sizes, methodological heterogeneity, and limited longitudinal data can’t lead to definitive conclusions, requiring the need for larger, well-designed studies to validate IL-4/IL-13 as prognostic biomarkers and therapeutic targets in COPD.

Zitieren

APA

Para, O., Raza, A., Carleo, C., Vanetti, M., & Spanevello, A. (2026). Clinical and biomarker significance of interleukin-4 and interleukin-13 in acute exacerbations and the frequent exacerbator phenotype of chronic obstructive pulmonary disease: a systematic review. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2026.4037

Vancouver

Para O, Raza A, Carleo C, Vanetti M, Spanevello A. Clinical and biomarker significance of interleukin-4 and interleukin-13 in acute exacerbations and the frequent exacerbator phenotype of chronic obstructive pulmonary disease: a systematic review. Monaldi Archives for Chest Disease. 2026. doi:10.4081/monaldi.2026.4037

BibTeX
@article{Para2026,
  author = {Para, Ombretta and Raza, Asim and Carleo, Christian and Vanetti, Marco and Spanevello, Antonio},
  title = {Clinical and biomarker significance of interleukin-4 and interleukin-13 in acute exacerbations and the frequent exacerbator phenotype of chronic obstructive pulmonary disease: a systematic review},
  journal = {Monaldi Archives for Chest Disease},
  year = {2026},
  doi = {10.4081/monaldi.2026.4037}
}
Kostenlos starten →